Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. The
primary prevention of CVD is dependent upon the ability to identify high-risk individuals long …

Present review article highlights various cardiovascular risk prediction biomarkers by
incorporating both traditional risk factors to be used as diagnostic markers and recent …

Van Tassell et al IL-1 and Heart Disease 1911 progression of coronary artery disease and
impaired function. Nevertheless, reports of an inflammatory response during heart disease …

Since natriuretic peptides were successfully integrated into the clinical practice of heart
failure (HF), the possibility of using new biomarkers to advance the management of affected …

Measurement of biomarkers has revolutionized the work-up of patients with suspected
cardiovascular disease. The most widely used contemporary cardiovascular biomarkers are …

Tape-stripping is a minimally invasive approach for skin sampling that captures the
cutaneous immune/barrier abnormalities in atopic dermatitis (AD). However, tape-strips …

Abstract Interleukin 33 (IL-33), which is expressed by several immune cell types, endothelial
and epithelial cells, and fibroblasts, is a cytokine of the IL-1 family that acts both intra-and …

Background Several biomarkers have individually been shown to be useful for risk
stratification in patients with acute myocardial infarction (MI). The optimal multimarker …

Cardiovascular diseases (CVDs) are a major healthcare burden on the population
worldwide. Early detection of this disease is important in prevention and treatment to …

Cardiovascular diseases (CVD) are the major cause of death worldwide. The identification
of markers able to detect the early stages of such diseases and/or their progression is …